Our guide to your first call to a rehab covers the informal, no-commitment conversation that starts the process. This piece covers what comes after someone decides to move forward: the formal, structured clinical assessment used to actually build a treatment plan and determine level of care. These are genuinely different conversations, and knowing what to expect from the second one removes a lot of unnecessary anxiety.
Most licensed, accredited treatment programs in the United States structure their pre-admission assessment around the ASAM Criteria, developed by the American Society of Addiction Medicine, currently in its fourth edition. This is not one questionnaire but a comprehensive biopsychosocial assessment across six defined dimensions, each rated for severity, that together determine which level of care is clinically appropriate and safe. Understanding these six dimensions in advance makes the assessment feel considerably less like an interrogation and considerably more like what it actually is: a structured process for making sure you land in the right level of care the first time.
This framework did not emerge overnight. It has been refined through multiple editions since the first ASAM Patient Placement Criteria in 1991, developed and maintained by a coalition representing major stakeholders across the addiction treatment field. The goal behind this ongoing refinement is consistency: two people assessed at different facilities, using the same framework, should arrive at broadly comparable level-of-care recommendations for similar clinical pictures, which is part of why insurers increasingly expect documentation tied specifically to these six dimensions when reviewing requests for coverage of higher levels of care.
A properly conducted assessment walks through all six dimensions in order rather than skipping around based on what seems most urgent in the moment. This structure matters because severity in a single dimension, even one that looks low-risk on its own, can change the overall picture. Clinical documentation guidance specifically warns against skipping dimensions: someone with low severity across five dimensions but high severity in Dimension 6, for example, someone whose only viable living situation after discharge is an environment where substance use is normalized, may actually need a higher level of care than someone with moderate severity spread evenly across all six areas. This is why a rushed, informal assessment that only covers substance use history and skips the environmental and psychiatric dimensions can produce a genuinely wrong level-of-care recommendation.
| Dimension | What It Covers | Sample Questions |
|---|
| 1. Acute intoxication and withdrawal potential | Current substance use, last use, and withdrawal risk | What substance, how much, how often, and when was your last use? Have you experienced withdrawal symptoms before, including seizures or hallucinations? |
| 2. Biomedical conditions and complications | Physical health history relevant to treatment and safety | Do you have any chronic medical conditions? Are you currently taking any medications? Any recent injuries, infections, or hospitalizations? |
| 3. Emotional, behavioral, and cognitive conditions | Mental health history and current symptoms, often using validated tools like the PHQ-9 for depression and GAD-7 for anxiety | Have you been diagnosed with a mental health condition? Are you currently experiencing thoughts of harming yourself or others? |
| 4. Readiness to change | Motivation and engagement with the idea of treatment | What brought you to seek help now? How do you feel about the idea of stopping or changing your use? |
| 5. Relapse, continued use, or continued problem potential | History of prior treatment attempts and what happened afterward | Have you been in treatment before? What happened when you left? What situations make it hardest to avoid using? |
| 6. Recovery environment | Living situation, relationships, work, and other environmental factors | Who do you currently live with? Is your home environment supportive of recovery? Do you have reliable transportation and housing after treatment? |
Many people expect a pre-admission assessment to be purely about substance use history and expect to be judged for any ambivalence about getting sober. The readiness dimension exists precisely because clinicians understand ambivalence as a normal, expected clinical factor rather than a disqualifying one. A low readiness score is not a reason to deny care; research-informed guidance treats ambivalence as information that shapes the treatment approach, often pointing toward more structure rather than less, not as a reason to turn someone away or make them feel judged for being unsure.
This dimension connects directly to concepts covered in our guide to motivational interviewing, since a low readiness score often signals that MI-based approaches, rather than direct confrontation, will be the more clinically appropriate starting point for that person's early treatment. A good assessment does not treat ambivalence as a problem to be fixed before treatment can begin; it treats ambivalence as clinical information that shapes how treatment begins.
Beyond the conversational interview, most thorough assessments include one or more brief, standardized questionnaires: the AUDIT for alcohol use severity, the DAST-10 for drug use severity, the PHQ-9 for depression, the GAD-7 for anxiety, and often the Columbia Suicide Severity Rating Scale as a safety screen. If withdrawal risk is a concern, the COWS scale for opioids or CIWA-Ar scale for alcohol may also be used. These are not pass-fail tests. They exist to standardize how severity is measured across patients and to make sure nothing important gets missed in a conversational interview alone, and most take only a few minutes each to complete.
Consider someone completing a pre-admission assessment for alcohol use disorder. Across Dimension 1, they disclose daily heavy drinking and a prior withdrawal seizure, immediately flagging a need for medically supervised detox. Across Dimension 3, their PHQ-9 score indicates moderate depression, which the assessment team notes should be reassessed after a period of abstinence, consistent with how substance-induced versus independent depression gets distinguished clinically. Across Dimension 6, they disclose that their home environment includes another person who drinks heavily, a detail that shapes the recommendation toward a longer residential stay or a sober living step-down rather than a quick return home. No single answer determined their treatment plan; the combination across all six dimensions did, which is exactly why a thorough, honest assessment matters more than any single question within it.
It can be tempting to minimize certain answers, particularly around quantity of use or mental health symptoms, out of embarrassment or a desire to seem more in control of the situation than may be true. But the entire point of this assessment is to place you in the safest, most clinically appropriate level of care, and an inaccurate picture undermines that goal directly. Our guide to whether you need detox before alcohol rehab covers one specific, serious consequence of underreporting: arriving at a facility not equipped for the withdrawal risk your actual history would have indicated.
It is also worth understanding that assessors are trained to expect some degree of minimization, particularly around quantity of substance use, and are not easily thrown off by an imperfect self-report. A skilled assessor will often ask the same underlying question in a few different ways over the course of the conversation, partly to catch inconsistencies and partly because people genuinely remember details more accurately as a conversation progresses and trust builds. This means a slightly inconsistent early answer is not a crisis; what matters most is correcting the record as clearly as possible once you realize an earlier answer understated something, rather than continuing to build on an inaccurate initial picture.
- A list of current medications, including dosages, if available
- A general timeline of your substance use history, even if approximate
- Information about any prior treatment episodes and what levels of care you received
- Insurance information, if applicable, so financial questions can be addressed alongside the clinical assessment
- Honest answers, even to the questions that feel uncomfortable, since incomplete information leads to a less accurate level-of-care recommendation
Once your assessment is complete and a level of care is determined, our guide to inpatient versus outpatient treatment can help you understand what that recommendation actually means in practice, and our guide to building an aftercare plan is worth reviewing early, since good discharge planning starts well before you finish treatment.
Frequently asked questions
Most licensed, accredited programs use the ASAM Criteria, a comprehensive biopsychosocial assessment across six defined dimensions that together determine the clinically appropriate level of care.
Acute intoxication and withdrawal potential, biomedical conditions, emotional and behavioral conditions, readiness to change, relapse potential, and recovery environment.
No. Readiness to change is one of the six assessed dimensions, and clinical guidance treats ambivalence as a normal, expected factor that shapes the treatment approach, not a disqualifying reason to deny care.
Common tools include the AUDIT for alcohol severity, DAST-10 for drug severity, PHQ-9 for depression, GAD-7 for anxiety, and the Columbia Suicide Severity Rating Scale, alongside withdrawal risk tools like COWS or CIWA-Ar if relevant.
A list of current medications, a general substance use timeline, information about prior treatment episodes, and insurance information if applicable.
The assessment determines the safest, most clinically appropriate level of care for you specifically. Minimizing answers, particularly around substance quantity or withdrawal history, can result in placement that isn't equipped to manage your actual risk.
This article was reviewed by the RehabsNearMe Editorial Team for accuracy, clarity, and relevance. Information may be sourced from publicly available treatment resources, government agencies, and healthcare references where applicable.
Last reviewed: September 2026
Related articles
Resources
